)
Bangkok Dusit Medical Services (BDMS) investor relations material
Bangkok Dusit Medical Services Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Operating income grew 1% year-over-year to THB 27,514M in 2Q26 and THB 56,068M for 6M26, supported by higher revenue intensity and international patient growth, despite regional tensions.
Interim financials for the three- and six-month periods ended 30 June 2026 were reviewed with no material misstatements found.
Main business remains hospital operations, with supporting businesses contributing less than 10% of revenue.
Net profit after tax (NPAT) declined 7% year-over-year in both 2Q26 and 6M26, mainly due to higher depreciation from network expansion.
Revenue momentum accelerated in July 2026, with hospital revenue up 8% year-over-year, driven by increased inpatient admissions and international patient demand.
Financial highlights
Consolidated revenue for Q2 2026 was THB 27,542 million, up 1.4% year-over-year.
For H1 2026, consolidated revenue reached THB 56,106 million, up 0.9% year-over-year.
EBITDA margin compressed to 22.0% in 2Q26 and 23.3% in 6M26, down from 22.6% and 24.1% respectively, due to higher depreciation.
EBIT margin declined to 15.5% in 2Q26 and 17.0% in 6M26.
Net profit for Q2 2026 was THB 3,370 million, down 6.9% year-over-year.
Outlook and guidance
Revenue growth accelerated in July 2026, with occupancy rates improving to 65% and strong demand from both Thai and international patients.
International patient bookings surpassed 40,000 as of August 2026, with continued rebound in Middle East revenue.
Management is evaluating the impact of TFRS 18, effective 2028, on future financial statements.
- Southeast Asia's largest health-tech provider leads in diagnostics, genomics, and regional expansion.BDMS
Corporate presentation - Flat operating income and hospital revenue, with a THB 1 per share dividend approved.BDMS
Q1 2026 - 2025 saw 4% YoY growth in operating income and hospital revenue, led by international patient gains.BDMS
Q4 2025 - Net profit rose to ฿12.16 billion on higher revenue, international growth, and network expansion.BDMS
Q3 2025 - Revenue and profit grew 5–6% YoY, led by international patients and strong hospital operations.BDMS
Q2 2025 - 9M24 net profit rose 12% to ฿11.65 billion on revenue of ฿81.6 billion, driven by patient growth.BDMS
Q3 2024 - Net profit rose 14% in H1 2024, driven by hospital growth and international patient revenue.BDMS
Q2 2024 - Net profit rose over 6% YoY, supported by international and upcountry hospital growth.BDMS
Q1 2025 - 2024 saw double-digit net profit growth, strong international patient demand, and major expansion projects.BDMS
Q4 2024
Next Bangkok Dusit Medical Services earnings date
Next Bangkok Dusit Medical Services earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)